Исследование митогенетических сигнальных путей в клетке у онкологических больных с помощью программного комплекса OncoFinder

Литература:
1. Таргетная терапия рака молочной железы (новые направления) / В.Ф. Семиглазов, ГА. Дашян, В. В. Семиглазов [и др.]//Фарматека. 2011. №7. С. 14-20; 2. Жуков Н.В., Тюляндин С. А. Целевая терапия в лечении солидных опухолей: практика противоречит теории // Биохимия. 2008. Т. 73. № 5. С. 751-768; 3. Giezen T.J., Mantel-Teeuwisse А. К., Strauss S., Schellekens Н. Safety-related regulatory actions for biologicals approved in the United States and the European Union // JAMA. 2008. Vol. 300. P. 1887-1896; 4. Bustin S. A. Absolute quantification of mRNA using realtime reverse transcription polymerase chain reaction assays // Journal of Molecular Endocrinology. 2000. Vol. 25. P. 169-193; 5. Studencki А. В., Conner B.J., Impraim C.C., Teplitz R.L., Wallace R. B. Discrimination among the human beta A, beta S, and beta C-globin genes using allele-specific oligonucleotide hybridization probes//Am. J. Hum. Genet. 1985. Vol. 37. P. 42-51; 6. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries / L. Diatchenko, Y. Lau, A. Campbell [et al.] // Proc. Natl. Acad.Sci. USA. 1996. Vol. 93. P. 6025-6030; 7. Enzymatic production of RNAi libraries from cDNAs / D. Shirane, K. Sugao, S. Namiki [et al.] // Nature Genetics. 2004. Vol. 36. P. 190-196; 8. Black D. L. Mechanisms of alternative pre-messenger RNA splicing // Annual Reviews of Biochemistry. 2003. Vol. 72. P. 291-336; 9. Targeted capture and massively parallel sequencing of 12 human exomes / S. B. Ng, E. H. Turner, P. D. Robertson [et al.] // Nature. 2009. Vol. 461. P. 272-276; 10. Scaffolding protein GAB1 sustains epidermal growth factor-induced mitogenicand survival signaling by multiple positive feedback loops/A. Kiyatkin, E. Aksamitiene, N.I. Markevich [et al.]//J. Biol. Chem. 2006. Vol. 281. P. 19925-19938; 11. Systems-level interactions between insulin-EGF networks amplify mitogenic signaling/N. Borisov, E. Aksamitiene, A. Kiyatkin [et al.] // Mol. Syst. Biol. 2009. Vol. 5, article number 256; 12. Kuzmina N.B., Borisov N.M. Handling complex rule-based models of mitogenic cell signaling (On the example of ERK activation upon EGF stimulation) // Intl. Proc. Chem. Biol. Envir Engng. 2011. Vol. 5. P. 76-82; 13. SABiosciences, a Qiagen company. URL: http://www.sabiosciences.com/pathwaycentral.php (дата обращения: 20.11.2013); 14. GEO Profiles, a National Center of Biotechnology Information database. URL: http://www.ncbi.nlm.nih.gov/ geoprofiles/(дата обращения: 20.11.2013); 15. Cell line derived multi-gene predictor of pathologic response to neoadjuvant chemotherapy in breast cancer: a validation study on US Oncology 02-103 clinical trial / K. Shen, Y Qi, N. Song [et al.] // ВМС Med. Genomics. 2012. Vol. 4, article number 51; 16. Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+ERa-breast cancer/J. С Liu, V Voisin, G D. Bader [et al.] // Proc. Natl. Acad. Sci. USA. Vol. 109. P. 5832-5837; 17. Van der Kogel A., Joiner M. Basic Clinical Radiobiology Fourth edition. Oxford university press, 2009; 18. New specific molecular targets for radio-chemotherapy of rectal cancer / K. Snipstad, С G Fenton, J. Kjaeve [et al.] // Mol. Oncol. 2010. Vol. 4. P. 52-64.